<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 18, 2000
NMT Medical, Inc.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
Delaware 000-21001 95-4090463
--------------------------------------------------------------------------------
(State or other juris- (Commission (IRS Employer
diction of incorporation) File Number) Identification No.)
27 Wormwood Street, Boston, Massachusetts 02210
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (617) 737-0930
N/A
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events.
------------
On July 18, 2000, NMT Medical, Inc. (the "Company") issued a press release
announcing that the Board of Directors of the Company has restructured the
interim management team so as to allow the Office of the President to have more
of the day-to-day operating responsibilities. Accordingly, Jeffrey R. Jay,
M.D., the Chairman of the Board, and R. John Fletcher, a member of the Board,
have each resigned as Acting Co-Chief Executive Officer. William J. Knight, Vice
President of Finance and Administration and Chief Financial Officer, and Rudy
Davis, Vice President of Sales and Marketing, will each continue to serve as
Acting Co-President. The full text of the Company's press release is filed as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by
reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
------------------------------------------------------------------
(c) Exhibits
Exhibit No. Description
----------- -----------
99.1 Press Release, dated July 18, 2000, announcing the restructuring
of the interim management team of NMT Medical, Inc.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 19, 2000 NMT Medical, Inc.
-----------------
(Registrant)
By: /s/ Randall W. Davis
-----------------------------
Name: Randall W. Davis
Title: Acting Co-President
-3-
<PAGE>
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press Release, dated July 18, 2000, announcing the restructuring
of the interim management team of NMT Medical, Inc.
